Evidence map›Paper›PMID 33169195›Full record

ArticleVirchows Archiv : an international journal of pathology2021

Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases.

Akira Satou, Tetsuya Tabata, Yuka Suzuki, Yasuharu Sato, Ippei Tahara, Kunio Mochizuki, Naoki Oishi, Taishi Takahara, Tadashi Yoshino, Toyonori Tsuzuki and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Programmed cell death-ligand 1 (PD-L1)Clinical and experimental medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Akira SatouDepartment of Surgical Pathology, Aichi Medical University Hospital, 1-1, Yazakokarimata, Nagakute, 480-1195, Japan. satoakira@aichi-med-u.ac.jp.ORCID http://orcid.org/0000-0002-7921-6087
Tetsuya TabataDepartment of Pathology, Okayama University Graduate School of Medicine, Okayama, Japan.
Yuka SuzukiDepartment of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
Yasuharu SatoDivision of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama, Japan.
Ippei TaharaDepartment of Pathology, Graduate School of Medicine, University of Yamanashi, Chuo, Japan.
Kunio MochizukiDepartment of Pathology, Graduate School of Medicine, University of Yamanashi, Chuo, Japan.
Naoki OishiDepartment of Pathology, Graduate School of Medicine, University of Yamanashi, Chuo, Japan.
Taishi TakaharaDepartment of Surgical Pathology, Aichi Medical University Hospital, 1-1, Yazakokarimata, Nagakute, 480-1195, Japan.
Tadashi YoshinoDepartment of Pathology, Okayama University Graduate School of Medicine, Okayama, Japan.
Toyonori TsuzukiDepartment of Surgical Pathology, Aichi Medical University Hospital, 1-1, Yazakokarimata, Nagakute, 480-1195, Japan.
Shigeo NakamuraDepartment of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
Okayama University · JPUniversity of Yamanashi · JPAichi Medical University Hospital · JPNagoya University Hospital · JPAichi Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasma cell differentiation (PCD) is frequently observed in some entities of non-Hodgkin B cell lymphoma, including both low-grade and high-grade lymphomas. However, except for plasmablastic lymphoma and primary effusion lymphoma, EBV

Indexed as

Cell DifferentiationAgedAged, 80 and overAntirheumatic AgentsBiomarkers, TumorB-LymphocytesDiagnosis, DifferentialEpstein-Barr Virus InfectionsFemaleGenes, Immunoglobulin Heavy ChainGenes, T-Cell Receptor gammaHerpesvirus 4, HumanHost-Pathogen InteractionsHumansLymphoma, Large B-Cell, DiffuseLymphoproliferative DisordersAntirheumatic AgentsBiomarkers, TumorMethotrexateEpstein-Barr virusIGH and TCRγ PCRMott cellPlasma cell differentiationPolymorphic lymphoproliferative disorder

Identifiers

PMID33169195
OpenAlexW3098001263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.